IBIO, INC. Form PRE 14A: Preliminary proxy statement
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2026-08-20: Form PRE 14A; Period of report 2026-10-14; Description PRE 14A; Document ibio-20261014xpre14a.htm.
- 2023-10-16: Form PRE 14A; Period of report 2023-11-27; Description PRE 14A; Document tmb-20231127xpre14a.htm.
- 2022-05-12: Form PRE 14A; Period of report 2022-06-30; Description PRE 14A; Document tmb-20220630xpre14a.htm.
- 2021-10-13: Form PRE 14A; Period of report 2021-12-09; Description PRE 14A; Document tm2129710d1_pre14a.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2026-08-20 | PRE 14A | 2026-10-14 | PRE 14A | ibio-20261014xpre14a.htm |
| 2023-10-16 | PRE 14A | 2023-11-27 | PRE 14A | tmb-20231127xpre14a.htm |
| 2022-05-12 | PRE 14A | 2022-06-30 | PRE 14A | tmb-20220630xpre14a.htm |
| 2021-10-13 | PRE 14A | 2021-12-09 | PRE 14A | tm2129710d1_pre14a.htm |
| 2020-10-23 | PRE 14A | 2020-12-09 | PRE 14A | tm2034104d1_pre14a.htm |
| 2020-01-13 | PRE 14A | 2020-02-10 | PRELIMINARY PROXY STATEMENT | tv536154-pre14a.htm |
| 2018-11-09 | PRE 14A | 2018-12-18 | PRELIMINARY PROXY STATEMENT | tv506503-pre14a.htm |
| 2018-03-21 | PRE 14A | 2018-04-23 | PRE 14A | tv489113_pre14a.htm |
| 2017-11-15 | PRE 14A | 2017-11-15 | PRE 14A | tv479486_pre14a.htm |
| 2016-02-29 | PRE 14A | 2016-02-29 | PRE 14A | v433031_pre14a.htm |
| 2013-11-05 | PRE 14A | 2013-11-05 | PRE 14A | v359436_pre14a.htm |
| 2010-10-28 | PRE 14A | 2010-12-08 | Preliminary proxy statement | c63165_pre14a.htm |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |